A
ABEO
Abeona Therapeutics Inc. Common Stock
$4.36
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Abeona Therapeutics Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$1.12
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.16
Nov 10
Posts
No posts about ABEO yet.
About Abeona Therapeutics Inc. Common Stock
Abeona Therapeutics is a US biotechnology company that develops gene and cell therapies for rare skin diseases. Its main product treats a severe inherited skin blistering condition called recessive dystrophic epidermolysis bullosa, using a patient's own gene-corrected skin cells. The company earns money by selling this one-time treatment to specialty treatment centers, and revenue is still early and small.